Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives

Fig. 4

Treatment of DN with nanomaterials. In the treatment of DN, the therapeutic forms of nanoparticles include the therapeutic effect of nanoparticles themselves, the combination of nanoparticles and drugs, and the nanodrug delivery system, which can target podocytes, mesangial cells and mesangium. DN diabetic nephropathy, PCL-PEI  polycaprolactone-polyethyleneimine, RH  rhein; DXM  dexamethasone

Back to article page